with a disulfide as acceptor (1.17.3)

Industry

CPC
C12Y117/04

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y117/00Oxidoreductases acting on CH or CH2 groups (1.17)

Current Industry

C12Y117/04with a disulfide as acceptor (1.17.3)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for inhibiting expression of RRM2 genes
- Patent number 11,920,134
- Issue date Mar 5, 2024
- Arrowhead Pharmaceuticals, Inc.
- John Frederick Boylan
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Enzyme products
- Patent number 11,286,474
- Issue date Mar 29, 2022
- c-LEcta GmbH
- Stefan Schoenert
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions useful in generating non canonical CD8+ T...
- Patent number 11,091,779
- Issue date Aug 17, 2021
- Oregon Health & Science University
- Klaus Frueh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for inhibiting expression of RRM2 genes
- Patent number 10,619,160
- Issue date Apr 14, 2020
- Arrowhead Pharmaceuticals, Inc.
- John Frederick Boylan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for inhibiting expression of RRM2 genes
- Patent number 9,938,531
- Issue date Apr 10, 2018
- Arrowhead Pharmaceuticals, Inc.
- John Frederick Boylan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cell and gene based methods to improve cardiac function
- Patent number 9,868,937
- Issue date Jan 16, 2018
- University of Washington
- Michael Regnier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for inhibiting expression of RRM2 genes
- Patent number 8,946,176
- Issue date Feb 3, 2015
- Arrowhead Research Corporation
- John Frederick Boylan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination viral-based and gene-based therapy of tumors
- Patent number 6,602,499
- Issue date Aug 5, 2003
- The General Hospital Corporation
- E. Antonio Chiocca
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Suppression of malignancy utilizing ribonucleotide reductase R1
- Patent number 6,472,376
- Issue date Oct 29, 2002
- Genesense Technologies, Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
nrdG
- Patent number 6,287,804
- Issue date Sep 11, 2001
- SmithKline Beecham Corporation
- Michael Terence Black
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ribonucleotide diphosphate reductase, nrdF, of streptococcus pneumo...
- Patent number 6,190,881
- Issue date Feb 20, 2001
- SmithKline Beecham Corporation
- Michael Terence Black
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of identifying compounds that inhibit DNA synthesis in myco...
- Patent number 5,834,279
- Issue date Nov 10, 1998
- Trustees of the University of Pennsylvania
- Harvey Rubin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Methods and Compositions Useful In Generating Non Canonical CD8+ T...
- Publication number 20200392534
- Publication date Dec 17, 2020
- Oregon Health & Science University
- Klaus FRUEH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and Methods for Inhibiting Expression of RRM2 Genes
- Publication number 20200277610
- Publication date Sep 3, 2020
- Arrowhead Pharmaceuticals, Inc.
- John Frederick Boylan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENZYME PRODUCTS
- Publication number 20200140838
- Publication date May 7, 2020
- C-LECTA GMBH
- Stefan SCHOENERT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERING THE RRM2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE TO RESIST...
- Publication number 20200000886
- Publication date Jan 2, 2020
- University of Washington
- Michael REGNIER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS USEFUL IN GENERATING NON CANONICAL CD8+ T...
- Publication number 20180298404
- Publication date Oct 18, 2018
- Oregon Health & Science University
- Klaus FRUEH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and Methods for Inhibiting Expression of RRM2 Genes
- Publication number 20180195074
- Publication date Jul 12, 2018
- Arrowhead Pharmaceuticals, Inc.
- John Frederick Boylan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and Methods for Inhibiting Expression of RRM2 Genes
- Publication number 20170137827
- Publication date May 18, 2017
- Arrowhead Pharmaceuticals, Inc.
- John Frederick Boylan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELL AND GENE BASED METHODS TO IMPROVE CARDIAC FUNCTION
- Publication number 20160186139
- Publication date Jun 30, 2016
- University of Washington
- Michael Regnier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and Methods for Inhibiting Expression of RRM2 Genes
- Publication number 20120159657
- Publication date Jun 21, 2012
- John Frederick Boylan
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Suppression of malignancy utilizing ribonucleotide reductase R1
- Publication number 20030087866
- Publication date May 8, 2003
- GENESENSE TECHNOLOGIES INC.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
nrdG
- Publication number 20020098544
- Publication date Jul 25, 2002
- Michael Terence Black
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUPRESSION OF MALIGNANCY UTILIZING RIBONUCLEOTIDE REDUCTASE R1
- Publication number 20020004488
- Publication date Jan 10, 2002
- JIM A. WRIGHT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
nrdF
- Publication number 20010010912
- Publication date Aug 2, 2001
- Michael Terence Black
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

with a disulfide as acceptor (1.17.3)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Compositions and methods for inhibiting expression of RRM2 genes

Enzyme products

Methods and compositions useful in generating non canonical CD8+ T...

Compositions and methods for inhibiting expression of RRM2 genes

Compositions and methods for inhibiting expression of RRM2 genes

Cell and gene based methods to improve cardiac function

Compositions and methods for inhibiting expression of RRM2 genes

Combination viral-based and gene-based therapy of tumors

Suppression of malignancy utilizing ribonucleotide reductase R1

nrdG

Ribonucleotide diphosphate reductase, nrdF, of streptococcus pneumo...

Methods of identifying compounds that inhibit DNA synthesis in myco...

Patents Applicationslast 30 patents

Methods and Compositions Useful In Generating Non Canonical CD8+ T...

Compositions and Methods for Inhibiting Expression of RRM2 Genes

ENZYME PRODUCTS

ENGINEERING THE RRM2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE TO RESIST...

METHODS AND COMPOSITIONS USEFUL IN GENERATING NON CANONICAL CD8+ T...

Compositions and Methods for Inhibiting Expression of RRM2 Genes

Compositions and Methods for Inhibiting Expression of RRM2 Genes

CELL AND GENE BASED METHODS TO IMPROVE CARDIAC FUNCTION

Compositions and Methods for Inhibiting Expression of RRM2 Genes

Suppression of malignancy utilizing ribonucleotide reductase R1

nrdG

SUPRESSION OF MALIGNANCY UTILIZING RIBONUCLEOTIDE REDUCTASE R1

nrdF